152 related articles for article (PubMed ID: 37722503)
1. Pharmacist-driven deprescribing initiative in primary care.
Rea E; Portman D; Ioannou K; Lumley B
J Am Pharm Assoc (2003); 2024; 64(1):139-145. PubMed ID: 37722503
[TBL] [Abstract][Full Text] [Related]
2. Use of a Deprescribing Tool in an Interdisciplinary Primary-Care Patient-Aligned Care Team.
Nelson MW; Downs TN; Puglisi GM; Simpkins BA; Collier AS
Sr Care Pharm; 2022 Jan; 37(1):34-43. PubMed ID: 34953511
[No Abstract] [Full Text] [Related]
3. Informatics Tools in Deprescribing and Medication Optimization in Older Adults: Development and Dissemination of VIONE Methodology in a High Reliability Organization.
Winter SG; Sedgwick C; Wallace-Lacey A; Dickerson K; Battar S; Hung W
Clin Ther; 2023 Oct; 45(10):928-934. PubMed ID: 37690914
[TBL] [Abstract][Full Text] [Related]
4. A virtual breakthrough series collaborative to support deprescribing interventions across Veterans Affairs healthcare settings.
Phillips KK; Mecca MC; Baim-Lance AM; Schiller GS; Pruskowski JA; Ellis EC; Aponte-Rosario DS; Federovich-Hogan AL; Kossifologos AC; Martinez ED; Boockvar KS
J Am Geriatr Soc; 2023 Sep; 71(9):2935-2945. PubMed ID: 37337658
[TBL] [Abstract][Full Text] [Related]
5. Implementation of a Pharmacist-Driven Aspirin Deprescribing Protocol Among Older Veterans in a Primary Care Setting.
Varghese CJ; Grunske M; Nagy MW
Sr Care Pharm; 2024 Jun; 39(6):228-234. PubMed ID: 38803026
[No Abstract] [Full Text] [Related]
6. Implementation of a compulsory clinical pharmacist-led medication deprescribing intervention in high-risk seniors in the emergency department.
Jovevski JJ; Smith CR; Roberts JL; Dev S; Iloabuchi TC; Gruber EA; Williams MJ; Slaven JE; Mitchell AM
Acad Emerg Med; 2023 Apr; 30(4):410-419. PubMed ID: 36794336
[TBL] [Abstract][Full Text] [Related]
7. Impact of deprescribing rounds on discharge prescriptions: an interventional trial.
Edey R; Edwards N; Von Sychowski J; Bains A; Spence J; Martinusen D
Int J Clin Pharm; 2019 Feb; 41(1):159-166. PubMed ID: 30478496
[TBL] [Abstract][Full Text] [Related]
8. A pharmacist-led pilot program to facilitate deprescribing in a primary care clinic.
Clark CM; LaValley SA; Singh R; Mustafa E; Monte SV; Wahler RG
J Am Pharm Assoc (2003); 2020; 60(1):105-111. PubMed ID: 31690514
[TBL] [Abstract][Full Text] [Related]
9. Deprescribing for older people living in residential aged care facilities: Pharmacist recommendations, doctor acceptance and implementation.
Quek HW; Etherton-Beer C; Page A; McLachlan AJ; Lo SY; Naganathan V; Kearney L; Hilmer SN; Comans T; Mangin D; Lindley RI; Potter K
Arch Gerontol Geriatr; 2023 Apr; 107():104910. PubMed ID: 36565605
[TBL] [Abstract][Full Text] [Related]
10. Pharmacist-led medication assessment and deprescribing intervention for older adults with cancer and polypharmacy: a pilot study.
Whitman A; DeGregory K; Morris A; Mohile S; Ramsdale E
Support Care Cancer; 2018 Dec; 26(12):4105-4113. PubMed ID: 29869294
[TBL] [Abstract][Full Text] [Related]
11. Implementation of pharmacist-led deprescribing in collaborative primary care settings.
Trenaman SC; Kennie-Kaulbach N; d'Entremont-MacVicar E; Isenor JE; Goodine C; Jarrett P; Andrew MK
Int J Clin Pharm; 2022 Oct; 44(5):1216-1221. PubMed ID: 35794285
[TBL] [Abstract][Full Text] [Related]
12. Pharmacist-led medication review in a residential in-reach service leads to deprescribing.
Hui JH; Parikh S; Kouladjian O'Donnell L; Mcinerney B; Dillon L; Poojary S; Crabtree A
Australas J Ageing; 2023 Dec; 42(4):675-682. PubMed ID: 37198738
[TBL] [Abstract][Full Text] [Related]
13. Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial.
Balsom C; Pittman N; King R; Kelly D
Int J Clin Pharm; 2020 Aug; 42(4):1153-1167. PubMed ID: 32494991
[TBL] [Abstract][Full Text] [Related]
14. Assessment of a Medication Deprescribing Tool on Polypharmacy and Cost Avoidance.
Constantino-Corpuz JK; Alonso MTD
Fed Pract; 2021 Jul; 38(7):332-336. PubMed ID: 34733084
[TBL] [Abstract][Full Text] [Related]
15. Pharmacist-Led Deprescribing for Patients With Polypharmacy and Chronic Disease States: A Retrospective Cohort Study.
Chan M; Plakogiannis R; Stefanidis A; Chen M; Saraon T
J Pharm Pract; 2023 Oct; 36(5):1192-1200. PubMed ID: 35522029
[No Abstract] [Full Text] [Related]
16. Deprescribing as a Clinical Improvement Focus.
Dharmarajan TS; Choi H; Hossain N; Munasinghe U; Lakhi F; Lourdusamy D; Onuoha S; Murakonda P; Skokowska-Lebelt A; Kanagala M; Russell RO
J Am Med Dir Assoc; 2020 Mar; 21(3):355-360. PubMed ID: 31672564
[TBL] [Abstract][Full Text] [Related]
17. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.
McIntyre C; McQuillan R; Bell C; Battistella M
Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321
[TBL] [Abstract][Full Text] [Related]
18. Assessing an Interprofessional Polypharmacy and Deprescribing Educational Intervention for Primary Care Post-graduate Trainees: a Quantitative and Qualitative Evaluation.
Mecca MC; Thomas JM; Niehoff KM; Hyson A; Jeffery SM; Sellinger J; Mecca AP; Van Ness PH; Fried TR; Brienza R
J Gen Intern Med; 2019 Jul; 34(7):1220-1227. PubMed ID: 30972554
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of the evidence for deprescribing interventions among older people living with frailty.
Ibrahim K; Cox NJ; Stevenson JM; Lim S; Fraser SDS; Roberts HC
BMC Geriatr; 2021 Apr; 21(1):258. PubMed ID: 33865310
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
